home / stock / esaly / esaly articles

ESALY Articles, Eisai Co. Ltd. ADR - From 10/13/23

Stock Information
Company Name: Eisai Co. Ltd. ADR
Stock Symbol: ESALY
Market: OTC
Menu
ESALY ESALY Quote ESALY Short ESALY News ESALY Articles ESALY Message Board
Get ESALY Alerts

News, Short Squeeze, Breakout and More Instantly...
Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage | Benzinga

The U.S. Centers for Medicare and Medicaid Services has revised its policy permitting multiple uses of amyloid positron emission tomograp...
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready | Benzinga

Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic too...

LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly | Benzinga

Hampus Hillerstrom, CEO of the Down syndrome research organization LuMind IDSC, is advocating for access to Alzheimer's drugs made by Eisa...

Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi | Benzinga

Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (...
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer | Benzinga

Merck & Co Inc (NYSE: MRK) and Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) have provided updates on two Phase 3 trials, LEAP-006...

Previous 10 Next 10